임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

38건 표시

1상모집 중단 (진행 중)· Healthy Volunteers
Study to Assess Adverse Events and How Oral Emraclidine Moves Through the Body of Adult Healthy Volunteers
리드: 애브비
상세 →NCT07587008
1상모집 중단 (진행 중)· Healthy Volunteer
A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants
리드: 애브비
상세 →NCT06953934
1상모집 중단 (진행 중)· Healthy Volunteer
A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
리드: 애브비
상세 →NCT07502417
1상모집 중단 (진행 중)· Healthy Volunteer
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
리드: 애브비
상세 →NCT07414784
1상모집 중단 (진행 중)· Healthy Volunteer
A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers
리드: 애브비
상세 →NCT07413133
1상모집 중단 (진행 중)· Healthy Volunteer
A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants
리드: 애브비
상세 →NCT07071532
1상모집 중단 (진행 중)· Healthy Volunteer
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcutaneous or Intravenous Doses of ABBV-701 in Healthy Adult Western and Asian Participants
리드: 애브비
상세 →NCT06895343
1상모집 중단 (진행 중)· Chronic Lymphocytic Leukemia
A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
리드: 애브비
상세 →NCT06291220
1상모집 중단 (진행 중)· Healthy Volunteer
A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants
리드: 애브비
상세 →NCT06673238
1상모집 중단 (진행 중)· Colorectal Cancer
Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer
리드: 애브비
상세 →NCT06464692
1상모집 중단 (진행 중)· Multiple Myeloma
Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma
리드: 애브비
상세 →NCT06223516
1상모집 중단 (진행 중)· Metastatic Castration-Resistant Prostate Cancer
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
리드: 애브비
상세 →NCT06318273
1상모집 중단 (진행 중)· Acute Myeloid Leukemia
Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
협력: 애브비
상세 →NCT06034470
1상모집 중단 (진행 중)· Hepatocellular Carcinoma
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
리드: 애브비
상세 →NCT06084481
1상모집 중단 (진행 중)· Hematologic Cancer
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies
리드: 애브비
상세 →NCT05753501
1상모집 중단 (진행 중)· Diffuse Large B-Cell Lymphoma
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
리드: 애브비
상세 →NCT05618028
1상모집 중단 (진행 중)· Endometrial Cancer
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
리드: 애브비
상세 →NCT05527184
1상모집 중단 (진행 중)· Advanced Solid Tumors
Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors
리드: 애브비
상세 →NCT05599984
1상모집 중단 (진행 중)· Relapsed/Refractory Multiple Myeloma
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
리드: 애브비
상세 →NCT05259839
1상모집 중단 (진행 중)· Non-hodgkin Lymphoma
Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab
협력: 애브비
상세 →NCT05206357
1상모집 중단 (진행 중)· B Acute Lymphoblastic Leukemia
Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia
협력: 애브비
상세 →NCT04872790
1상모집 중단 (진행 중)· Myeloid Malignancy
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
협력: 애브비
상세 →NCT05455294
1상모집 중단 (진행 중)· Relapsed/Refractory Multiple Myeloma
A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
리드: 애브비
상세 →NCT05308654
1상모집 중단 (진행 중)· Relapsed/Refractory Multiple Myeloma
A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan
리드: 애브비
상세 →NCT05286229
1상모집 중단 (진행 중)· Acute Leukemia of Ambiguous Lineage in Relapse
Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
협력: 애브비
상세 →NCT04898894
1상모집 중단 (진행 중)· Non-Small Cell Lung Cancer
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab
리드: 애브비
상세 →NCT05029882
1상모집 중단 (진행 중)· B-cell Acute Lymphoblastic Leukemia
Venetoclax Plus Inotuzumab for B-ALL
협력: 애브비
상세 →NCT05016947
1상모집 중단 (진행 중)· Advanced Solid Tumors Cancer
Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors
리드: 애브비
상세 →NCT04721015
1상모집 중단 (진행 중)· Myelofibrosis (MF)
Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis
리드: 애브비
상세 →NCT04454658
1상모집 중단 (진행 중)· Acute Myeloid Leukemia
Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
협력: 애브비
상세 →NCT03844815
1상모집 중단 (진행 중)· Myeloproliferative Neoplasm
A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm
리드: 애브비
상세 →NCT04041050
1상모집 중단 (진행 중)· Juvenile Idiopathic Arthritis (JIA)
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
리드: 애브비
상세 →NCT03725007
1상모집 중단 (진행 중)· Cancer
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
리드: 애브비
상세 →NCT03893955
1상모집 중단 (진행 중)· Advanced Solid Tumors Cancer
Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors
리드: 애브비
상세 →NCT03821935
1상모집 중단 (진행 중)· Acute Myeloid Leukemia
Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
협력: 애브비, 로슈
상세 →NCT03709758
1상모집 중단 (진행 중)· Advanced Solid Tumors Cancer
A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
리드: 애브비
상세 →NCT02988960
1상모집 중단 (진행 중)· Myelodysplastic Syndromes (MDS)
A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)
리드: 애브비 · 협력: 로슈
상세 →NCT02942290
1상모집 중단 (진행 중)· Advanced Solid Tumors Cancer
A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors
리드: 애브비
상세 →NCT02099058

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.